Fri, November 18, 2022
Thu, November 17, 2022
Wed, November 16, 2022
Tue, November 15, 2022
Mon, November 14, 2022

Salim Syed Maintained (UBX) at Strong Buy with Decreased Target to $12 on, Nov 16th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-12-on-nov-16th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Salim Syed of Mizuho, Maintained "Unity Biotechnology, Inc." (UBX) at Strong Buy with Decreased Target from $80 to $12 on, Nov 16th, 2022.

Salim has made no other calls on UBX in the last 4 months.



There are 3 other peers that have a rating on UBX. Out of the 3 peers that are also analyzing UBX, 0 agree with Salim's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Salim


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $10 on, Wednesday, November 9th, 2022
  • Andreas Argyrides of "Wedbush" Maintained at Buy with Increased Target to $36 on, Wednesday, November 2nd, 2022
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $80 on, Monday, August 15th, 2022